Prescription drug · ANDA
Dexamethasone NDC 81033-010
Dexamethasone .5 mg/5mL · Elixir · Oral · Kesin Pharma Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 81033-010-24 | 8103300102481033001024 | 20 CUP, UNIT-DOSE in 1 CARTON (81033-010-24) / 5 mL in 1 CUP, UNIT-DOSE (81033-010-05)Marketed from Nov 24, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Dexamethasone
- Generic name (nonproprietary)
- dexamethasone
- Active ingredients
- Dexamethasone — .5 mg/5mL
- Dosage form
- Elixir
- Route
- Oral
- Labeler
- Kesin Pharma CorporationNDC labeler code 81033
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 084754
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 81033-010_43e2a256-e024-5661-e063-6394a90af0e9SPL ID 43e2a256-e024-5661-e063-6394a90af0e9SPL set ID 43e2a24a-4465-5787-e063-6394a90a0b81RxCUI 309686UNII 7S5I7G3JQL
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N481033001024followed by a unit qualifier and the quantityPackage 81033-0010-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment: Atopic dermatitis Bronchial asthma Contact dermatitis Drug hypersensitivity reactions Seasonal or perennial allergic rhinitis Serum sickness Collagen Diseases During an exacerbation or as maintenance therapy in selected cases of: Systemic lupus erythematosus Acute rheumatic carditis. Dermatologic Disease Bullous dermatitis herpetiformis Exfoliative dermatitis Mycosis fungoides Pemphigus Severe erythema multiforme (Stevens-Johnson syndrome) Severe psoriasis Severe seborrheic dermatitis. Edematous States To induce a diuresis or remission of pro…
Excerpt only. Read the full label for complete information.
About NDC 81033-010
- What is NDC 81033-010?
- 81033-010 is the product NDC for Dexamethasone, Dexamethasone .5 mg/5mL elixir, listed with the FDA by Kesin Pharma Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Dexamethasone.
- What is the active ingredient?
- Dexamethasone.
- Who is the labeler?
- Kesin Pharma Corporation, NDC labeler code 81033. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Dexamethasone?
- 134 other product NDCs are listed under this name. See all Dexamethasone NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Dexamethasone products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Dexamethasone | Dexamethasone 4 mg/1 | TabletOral | Preferred Pharmaceuticals Inc | 68788-4113 | 68788-4113-0168788-4113-0368788-4113-05+1 more |
| Dexamethasone | Dexamethasone .5 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4669 | 70518-4669-00 |
| Dexamethasone | Dexamethasone .25 mg/1 | TabletOral | Pangea Pharmaceuticals, LLC | 81279-117 | 81279-0117-60 |
| Dexamethasone | Dexamethasone .5 mg/5mL | ElixirOral | ANI Pharmaceuticals, Inc. | 70954-872 | 70954-0872-10 |
| Dexamethasone | Dexamethasone 4 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-534 | 72789-0534-0172789-0534-2872789-0534-95 |
| Dexamethasone | Dexamethasone .5 mg/5mL | ElixirOral | Bryant Ranch Prepack | 72162-2600 | 72162-2600-02 |
| Dexamethasone | Dexamethasone .5 mg/5mL | ElixirOral | Kanchan Healthcare Inc | 85742-004 | 85742-0004-03 |
| Dexamethasone | Dexamethasone 1.5 mg/1 | TabletOral | NuCare Pharmaceuticals, Inc. | 68071-3962 | 68071-3962-03 |
| Dexamethasone | Dexamethasone .5 mg/1 | TabletOral | Advagen Pharma Ltd. | 72888-235 | 72888-0235-01 |
| Dexamethasone | Dexamethasone .75 mg/1 | TabletOral | Advagen Pharma Ltd. | 72888-236 | 72888-0236-01 |
Other NDCs under ANDA 084754
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Dexamethasone | Dexamethasone .5 mg/5mL | ElixirOral | Marlex Pharmaceuticals, Inc | 10135-795 |
| Dexamethasone | Dexamethasone .5 mg/5mL | ElixirOral | ANI Pharmaceuticals, Inc. | 70954-872 |
| Dexamethasone | Dexamethasone .5 mg/5mL | ElixirOral | Bryant Ranch Prepack | 72162-2600 |
| Dexamethasone | Dexamethasone .5 mg/5mL | ElixirOral | Kanchan Healthcare Inc | 85742-004 |